General Info
Unither Pharmaceuticals is a French manufacturer of dosage forms for pharmaceutical laboratories and generic products.
Location: Paris
Country:
Industries:
Investment Regions: EU
Investment Stages: late-stage, pre-seed, seed, series-a
Website: https://www.unither-pharma.com/
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Search found acquisition of a Novartis manufacturing site completed August 2023; no evidence of any startup investments or later investment activity through 2024-2025. The last known investment-related transaction (asset purchase) occurred more than 12 months ago (August 2023), so classify as not-active. The transaction involved the Novartis site (Butantã, São Paulo).
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Unither Pharmaceuticals
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI